Peter E. Boyd insider trades
Open-market stock purchases and sales by Peter E. Boyd, Chief People Officer at Aquestive Therapeutics, Inc, from SEC Form 4 filings since Jul 24, 2018.
Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +42%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 9, 2026 | AQST Aquestive Therapeutics, Inc | Bought (not open market) | $2.2K |
| Sep 9, 2026 | AQST Aquestive Therapeutics, Inc | Bought (not open market) | — |
| May 5, 2026 | AQST Aquestive Therapeutics, Inc | Sold (not open market) | $237K |
| Mar 10, 2026 | AQST Aquestive Therapeutics, Inc | Sold | $124K |
| Mar 9, 2026 | AQST Aquestive Therapeutics, Inc | Bought (not open market) | — |
| Mar 9, 2026 | AQST Aquestive Therapeutics, Inc | Bought (not open market) | $182K |
| Dec 4, 2025 | AQST Aquestive Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- AQST Aquestive Therapeutics, Inc: 5 buys, 4 sales, last Sep 9, 2026